Ranger Biotechnologies A/S
Biotechnology-Research
Website
Company Tagline
Therapeutic oligonucleotides
Industry Category
Business Keywords
Company Description
Ranger Biotechnologies A/S is a leading biotechnology research company focused on the development of therapeutic oligonucleotides. With a commitment to innovation and patient well-being, Ranger Biotechnologies A/S is dedicated to pioneering advancements in the field of gene expression modulation.
Ranger Biotechnologies A/S operates from its primary location at C.F. Tietgens Boulevard 30A, st., th., Odense SØ, South Denmark 5220, DK. The company leverages the unique Blockmir Technology platform, acquired in 2018, to target and block specific miRNA binding sites on individual mRNAs, achieving gene-specific upregulation on the protein level. This innovative approach distinguishes Ranger Biotechnologies A/S from other therapeutic modalities, offering a novel way to address a wide range of diseases.
Through a strategic alliance with MJJ Biotechnologies, Ranger Biotechnologies A/S is focused on developing new medicines for diseases of the liver, the CNS, and the eye. Ranger Biotechnologies A/S's technology is protected by a broad portfolio of patents, covering target mRNAs of numerous miRNAs, enabling the upregulation of thousands of different target mRNAs individually. We invite the manager of Ranger Biotechnologies A/S to create a customized and exclusive company showcase and product listing on our platform to further highlight its capabilities and solutions.
Ranger Biotechnologies A/S er en førende virksomhed inden for bioteknologisk forskning med fokus på udvikling af terapeutiske oligonukleotider. Med en forpligtelse til innovation og patienternes velvære er Ranger Biotechnologies A/S dedikeret til at bane vejen for fremskridt inden for genekspressionsmodulering.
Ranger Biotechnologies A/S opererer fra sin primære adresse på C.F. Tietgens Boulevard 30A, st., th., Odense SØ, Syddanmark 5220, DK. Virksomheden udnytter den unikke Blockmir Technology-platform, der blev erhvervet i 2018, til at målrette og blokere specifikke miRNA-bindingssteder på individuelle mRNA'er, hvilket opnår gen-specifik opregulering på proteinniveau. Denne innovative tilgang adskiller Ranger Biotechnologies A/S fra andre terapeutiske modaliteter og tilbyder en ny måde at behandle en bred vifte af sygdomme på.
Gennem en strategisk alliance med MJJ Biotechnologies er Ranger Biotechnologies A/S fokuseret på at udvikle ny medicin til sygdomme i leveren, CNS og øjet. Ranger Biotechnologies A/S's teknologi er beskyttet af en bred portefølje af patenter, der dækker mål-mRNA'er af adskillige miRNA'er, hvilket muliggør opregulering af tusindvis af forskellige mål-mRNA'er individuelt. Vi inviterer lederen af Ranger Biotechnologies A/S til at oprette en tilpasset og eksklusiv virksomhedspræsentation og produktliste på vores platform for yderligere at fremhæve virksomhedens kapaciteter og løsninger.
Key Personnel / Employees
Similar Companies
Other organizations in the same industry
FoodOxys PC Spin-off
Biotechnology-ResearchThe first spin-off company from UTH. Providing the AFQ CERT for agri-food products. Ensuring individ...
WorldPathol
Biotechnology-ResearchFamily company expert on biotech One Health solutions!
Alternative Company Names
This company is also known as